Table 4.
Univariable and multivariable analyses of predictors of DMFS and OS for propensity score-matched cohort in p-stage ≤ II patients.
| Clinical factors | Univariable analysis of DMFS | Univariable analysis of OS | |||||
|---|---|---|---|---|---|---|---|
| HR | 95%CI | p value | HR | 95%CI | p value | ||
| Age (≥60 v <60) | 1.057 | 0.646-1.730 | 0.824 | 1.515 | 0.844-2.718 | 0.164 | |
| Gender (female v male) | 0.815 | 0.497-1.337 | 0.418 | 0.630 | 0.351-1.132 | 0.122 | |
| T stage | 1.202 | 0.770-1.877 | 0.419 | 1 | 0.592-1.690 | 1.000 | |
| N stage | 2.387 | 1.380-4.127 | 0.002** | 2.236 | 1.198-4.175 | 0.011** | |
| Location (Peripheral v Central) | 0.645 | 0.259-1.608 | 0.347 | 0.640 | 0.230-1.781 | 0.640 | |
| pathology | |||||||
| Scc v Ad | 0.363 | 0.191-0.690 | 0.002** | 0.386 | 0.184-0.812 | 0.012** | |
| Others v Ad | 0.326 | 0.141-0.758 | 0.009** | 0.390 | 0.150-1.013 | 0.053 | |
| Chemotherapy# | 1.445 | 0.876-2.384 | 0.250 | 0.822 | 0.466-1.452 | 0.500 | |
| CTNB or non-biopsy | 1.720 | 1.041-2.844 | 0.034** | 1.652 | 0.951-2.948 | 0.090 | |
| Radiotherapy# | 3.829 | 1.194-12.280 | 0.024* | 3.891 | 1.205-12.568 | 0.023* | |
Abbreviations: CTNB, computed tomography-guided needle biopsy; Ad, adenocarcinoma; Scc: squamous-cell carcinoma; HR, hazard ratio; CI, confidence interval. *variables were Statistical significance in univariable analysis; **variables were also Statistical significance in multivariable analysis. #: adjuvant therapy.